Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioVectra, Keryx Enter Supply Agreement for Kidney Disease | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BioVectra, Keryx Enter Supply Agreement for Kidney Disease

The partnership revolves around the manufacture of Ferric Citrate, the API in Auryxia tablets

By: Betsy Louda

, Contract Pharma

BioVectra Inc. has announced a long-term supply agreement with Keryx Biopharmaceuticals to manufacture Ferric Citrate, the active pharmaceutical ingredient (API) in Auryxia tablets, a medicine approved for the treatment of two common complications of chronic kidney disease.

 

BioVectra brings over 45 years of contract development and manufacturing experience to the partnership. They have previously worked with Keryx to manufacture Ferric Citrate API since 2003. BioVectra will prepare for the anticipated growth in the long-term Ferric Citrate API supply needs by expanding production capacity at their headquarters facility in Charlottetown, PEI, Canada.

 

“With the recent U.S. FDA approval of Auryxia for a second indication, it is critical that we have sufficient manufacturing capacity to support anticipated future prescription demand,” said Melissa Bradford-Klug, chief business officer of Keryx Biopharmaceuticals. “BioVectra has been manufacturing the active pharmaceutical ingredient in Auryxia since 2003 and we believe they will be a great partner as we continue to expand the supply chain for Auryxia.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics